lifestyle.presbycamp.org

Author: Deerfield Group

Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting

March 17, 2026
Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia

March 5, 2026
K36 Therapeutics Completes Dosing of First Cohort in Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer, Announces New CMO

February 11, 2026
Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio

February 4, 2026
The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes (“T1D”) Therapies

January 23, 2026
Magnet Biomedicine Expands Leadership with Appointment of Nick Vlahakis, M.B.B.S., as Chief Medical Officer

January 13, 2026
Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 9, 2026
Muna Therapeutics Awarded $1 Million Alzheimer’s Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer’s

January 8, 2026
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria

January 8, 2026
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio

January 7, 2026